ACE and COVID-19: This viewpoint thus asserts that the generation of ROS, which has both primary (tissue damage) and secondary (signaling) is an important component of the vascular damage seen in COVID-19 and that ARB and ACE inhibitors, although freeing up ACE2, dampen ROS that causes microcapillary and intimal damage within the vascular system.